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a b s t r a c t
A syndrome of alternating hemiplegia of childhood (AHC) is a rare disorder ﬁrst presented in
1971. AHC is characterized by transient episodes of hemiplegia affecting either one or both sides
of the body. Age of onset is before 18 months and the common earliest manifestations are
dystonic or tonic attacks and nystagmus. Hemiplegic episodes last minutes to days and the
frequency and duration tend to decrease with time. Motor and intellectual development is
affected, deﬁcits may also develop later. Epileptic seizures occur in some patients. Neuroimaging
of the brain usually reveals no abnormalities. The variability of individual clinical presentations
and evolution of symptoms have made diagnosis difﬁcult. Therefore the problems of misdiag-
nosis could account for the low prevalence of this syndrome. This paper hopes to present actual
data on AHC, especially of the results of genetic research and new diagnostic tools.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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Alternating hemiplegia of childhood (AHC, MIM 104290) was
presented by Verret and Steel in 1971 [1]. Alternating hemiplegia
of childhood is a rare syndrome with an early manifestation,
and its diagnosis is based on the clinical symptoms fulﬁlling
the criteria. The incidence has been estimated at 1 in 1000,000
births but the underestimation of the burden of AHC could be
suspected due to the lack of sufﬁcient knowledge about this
syndrome or lack of diagnostic laboratory or radiological test
conﬁrming diagnosis with certainty [2]. Until recently, no
hypothesis explaining AHC pathomechanism has been con-
ﬁrmed. Although in single cases pathological changes were
detected suggesting vasculitis or mitochondrial enzymatic
chain disorders, speciﬁc marker of the disease was not deﬁned.
The phenotypic features common with migraine (hemiplegia as* Corresponding author at: Katedra Neurologii Dzieci i Młodzieży, UJ C
fax: +48 12 6581870.
E-mail address: agergon@cm-uj.krakow.pl (A. Gergont).
http://dx.doi.org/10.1016/j.pjnns.2013.05.003
0028-3843/# 2014 Polish Neurological Society. Published by Elsevier Ua symptom of motor migraine aura) suggested that AHC
constitutes migraine precursor or variant of hemiplegic
migraine (FHM, familial hemiplegic migraine). Majority of
presented cases were predominantly sporadic, however famil-
ial cases with transmission suggesting autosomal dominant
trait were presented [3,4].
Multicenter research on AHC pathomechanism succeeded
with the identiﬁcation of ATP1A3 mutation. The research was
conducted in collaboration with European Network for
Research on Alternating Hemiplegia (ENRAH), an organization
including patients and their families as well as clinicians to
help coordinate epidemiological data and to promote research
efforts [5,6].
The translation of the name of the syndrome into Polish
was not uniﬁed. In the publication of the Polish version of the
International Classiﬁcation of Headache Disorders 'alternating
plegia of childhood' (naprzemienne porażenie dziecięce) wasM ul. Wielicka 265, 30-663 Kraków, Poland. Tel.: +48 12 6581870;
rban & Partner Sp. z o.o. All rights reserved.
Table 1 – Diagnostic criteria for alternating hemiplegia of
childhood.
1. Onset before age of 18 months
2. Repeated episodes of hemiplegia involving alternating body
sides
3. Episodes of bilateral hemiplegia or quadriplegia, starting
bilaterally as separate attack or as generalization of a
hemiplegic episode
4. Disappearance of all symptoms upon sleeping
5. Other paroxysmal disturbances, including dystonic spells,
abnormal oculomotor symptoms or autonomic phenomena
occurring during hemiplegic spells or independently
6. Evidence of developmental delay or neurologic abnormalities,
including choreoatetosis, dystonia, or ataxia
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are commonly precursors of migraine [7]. A case of a patient
hospitalized at the Department of Developmental Neurology
AM in Gdańsk was presented in 1976 as 'alternating hemiple-
gia in a child' [8]. The next case of a girl with AHC hospitalized
at the Department of Neurology of Polish Mother's Memorial
Research Institute Hospital (Centrum Zdrowia Matki Polki) in
Łodź was described in 1995 as 'alternating hemiplegia' [9]. The
term 'alternating hemiplegia of childhood' was applied in the
paper related to the signiﬁcance of neuronal channelopathies
in the pathogenesis of migraine [10].
2. The classical course of AHC
In majority of children diagnosed with AHC, regardless of
climatic region, the key symptom, namely hemiplegia occurred
before 18 months of life. A plegia usually occurs during following
attacks at alternating body sides. Sometimes, however, it begins
unilaterally but later evolves to bilateral hemiplegia or transfers
to the opposite side of the body during one attack. Bilateral
plegia since the beginning of attacks was also observed during
some episodes. Deterioration of consciousness was not associ-
ated with episodes of hemiplegia. Involuntary movements,
including facial dyskinesia, dystonia and athetosis were
associated with hemiplegia or occurred independently. In
AHC cases manifesting during ﬁrst days of life, ocular
movement disorders or involuntary movements are the ﬁrst
to occur [11]. Later on, cerebellar ataxia appeared also with the
disease's progression. Headaches were reported by 58% of
children with AHC, although migraine with aura was diagnosed
in 16% [12]. Epileptic seizures were not in a close time relation to
hemiplegic episodes, but in some cases hemiplegia could be
incorrectly diagnosed as Todd palsy. In majority of children,
symptoms resolved during sleep, they appeared however
during prolonged attacks 10–20 min after awakening [13–15].
Diagnostic criteria of AHC are presented in Table 1 [13,14].
The criterion of immediate disappearance of all symptoms
while going to sleep was not always included as necessary to
establish diagnosis of AHC in retrospective research, since
responses in questionnaires did not contain such precise data
[15]. The early clinical signs recognized as most convincing for
diagnosis of AHC in infants included episodic nystagmus,
especially monocular [11]. Table 2 provides data related to
most important episodic AHC symptoms, especially mostTable 2 – Review of age of symptoms onset (months) and prev
hemiplegia of childhood.
Author Group Age of hemiplegia
onset (months); mean
O
Ag
Panagiotakaki et al. [12] 157 7 N
Sweney et al. [4] 103 6.6 2
Mikati et al. [15] 44 <18 (84%) N
>18 (16%)
Silver et al. [16] 10 9 N
Saito et al. [17] 9 8 3
Nevsimalová et al. [11] 8 16.3 4
ND – no data available.early symptoms: abnormal ocular symptoms and dystonia. In
relation to hemiplegia, which occurs in 100% of examined
patients, only the mean age of onset was presented. Table 3
shows data for most common non-episodic symptoms. The
table contains the year of paper's publication, the duration of
the research, and also the age of children at the time of
diagnosis [11,16,17]. There is a tendency for earlier AHC
diagnosis in younger patients. The data presented in papers
listed in references is more precise than included in tables. The
paper of Sweney et al. presents results of observations, that
episodic abnormal ocular movements were documented in
93% of patients, within 83% during ﬁrst 3 months of life, but in
32% in ﬁrst 2 days of life. Such information may have a
signiﬁcant impact on the early AHC diagnosis [4].
3. Stages of the course of AHC
Authors of the research on AHC noticed changes in clinical
symptoms with the age of children [4,11]. Mikati et al. [15]
proposed three phases of symptoms evolution in AHC
patients. These phases do not mean the constant deterioration
of development of patients but rather ﬂuctuations in their
condition. Stage I lasts for about one year and manifests itself
during ﬁrst months of life with episodic abnormal ocular
movements, such as horizontal, vertical or rotatory nystag-
mus, which can be also unilateral, gaze deviation to one side or
upwards, paralysis of conjugate gaze, loss of convergence or
convergent strabismus. Abnormal ocular movements were the
ﬁrst to occur in 83% of patients, as a presenting symptom [4].alence of episodic symptoms in patients with alternating
culomotor abnormalities Dystonia (%) Epilepsy (%)
e (months); mean %
D 91 88 53
.4 93 83 41
D 100 95 18
D ND ND 50
.2 100 89 77.7
.1 ND ND 87.5
Table 3 – Review of age of children at the time of diagnosis (months) and prevalence of symptoms significant for diagnosis
of alternating hemiplegia of childhood.
Author, year of publication Research duration Age at time of diagnosis
(months); mean
Developmental
delay (%)
Ataxia (%)
Panagiotakaki et al. (2010) [12] 2005–2007 20 92 ND
Sweney et al. (2009) [4] 1998–2007 36 100 96
Mikati et al. (2000) [15] 1995–2000 40 91 68
Silver et al. (1993) [16] ND 52 88.8 ND
Saito et al. (2010) [17] ND ND 100 ND
Nevsimalová et al. (2005) [11] ND 33 100 ND
ND – no data available.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 1 3 0 – 1 3 5132The earliest AHC manifestation, in the neonatal period, was
reported in 12.5% of examined patients not only as oculomotor
dysfunction, but also as involuntary movements including
dystonia, changes of behaviour or dysfunction of autonomic
nervous system [12,15]. Mild developmental delay was closely
associated with episodic symptoms [11,15].
During stage II, lasting for 1–5 years, patients began to have
hemiplegic spells, usually about 5 months after ﬁrst AHC
symptoms. However if hemiplegia had occurred earlier (in 32%
of patients as the ﬁrst symptom) than during this phase, the
hemiplegic spells became more frequent [15]. After the
incomplete recovery from hemiplegic spells, patients usually
achieved the ability of independent walking between 12 and 60
months of life. The gait was affected, by involuntary move-
ments, cerebellar ataxia and hypotonia persistent between
hemiplegic spells. Movement disorders inﬂuenced also ﬁne
motor skills, resulting in clumsiness [4,11]. Encephalopathy
with or without associated movement disorders was recog-
nized in 92–100% of patients, and in 20% of patients even
before the onset of typical symptoms of AHC. In other patients,
a loss of already acquired skills, called milestones of develop-
ment was observed [4,15]. Gross motor abnormalities were
diagnosed in 84% of children younger than 2 years [12].
Epilepsy manifested itself usually between second and
sixteenth year of life. A single seizure attack occurred in 53% of
the patients, and recurrent attacks were experienced by 18–
47% of the patients, as partial or partial with secondary
generalization [12,15]. Several types of epileptic seizures were
observed, including tonic–clonic, myoclonic and gelastic.
Usually seizures were not in close time relation to hemiplegic
spells. Status epilepticus of partial seizures was also reported
[12,15]. Epilepsy was relatively well controlled with medica-
tion. Dystonic spells were, however, resistant to antiepileptic
treatment, and electroencephalography performed during
attack did not register any epileptical patterns. Unfortunately,
in the case of hemiplegic episodes, an incomplete data
resulted in interpretation of hemiplegia as postictal one and
drug-resistant epilepsy was diagnosed [4,15,16].
During stage III, deﬁcits were persistent, with aphasia and
intellectual disability affecting school performance. With matu-
ration of the nervous system, hemiplegic spells became less
common but remission was incomplete and paresis persisted in
form of hemiplegia, tetraplegia, paraplegia or diplegia. The course
of the disease is unpredictable and ﬂuctuating [15,16]. The death
reported in 3–4% of patients was caused by status epilepticus,
severe plegia of limbs, cardiorespiratory insufﬁciency or dys-
function of the autonomic nervous system [4,12].4. The characteristics of hemiplegia
Premonitory signs prior to paroxysmal phenomena were
reported by 41% patients. The common associated with
hemiplegia symptoms were headaches in half of the patients,
mood disorders in 37% and vomiting in 10% of the patients.
Sensory phenomena involving hands and feet were also
reported. Premonitory phase may also consist of an alteration
in mental state with screaming, irritability or behavioral
changes [12,15]. Sudden and unexpected onset of hemiplegia
was also observed but always during awake stage with
hyperventilation or autonomic dysfunction [16,17]. In one of
presented cases, hemiplegia was precipitated by fever and
partial secondary generalized seizures [18]. Hemiplegia man-
ifested itself in half of the cases at about 6 months of age and
lasted between few minutes and 14 days. Hemiplegic spells
recurred with varying frequency, in the most severe cases
several times during the same day [18]. The triggering factor
was excitement, stress, tiredness, trauma, bright light, heat,
cold or a bath. In one patient, hemiplegia could be triggered by
induced crying, which was a precipitating factor in young
children [19,20]. Tetraplegia, especially ﬂaccid, was the least
common plegia type, causing not only immobilization of
patients but also speech problems (mainly dysarthria),
swallowing problems, and occasionally respiratory problems
including respiratory insufﬁciency in most severe cases [17].
Speech problems were observed only during right-sided
hemiplegic spells [12]. Deep tendon reﬂexes were absent in
majority of examined patients but in some patients brisk deep
tendon reﬂexes and Babinski sign were detected. Other
characteristic features of hemiplegia were ﬂuctuations in its
severity. Hemiplegia occurred more commonly in one side of
the body, but was more severe at the opposite body side [15].
Hemiplegic spells were accompanied by symptoms of
autonomic nervous system dysfunction and the most typical
were skin color changes, paleness, ﬂushing or sometimes
cyanosis, changes of pupil's diameter (myosis or mydriasis),
vomiting, diarrhea, sweating or the increase of body tempera-
ture [3,15,21].
5. AHC symptoms in adults
Since AHC was diagnosed in children, attention was also paid
to family members well-being. In a mother of one patient, mild
cognitive disorders were detected, and a broad-based gait.
Table 4 – Differential diagnosis of acute hemiplegia in
children.
Stroke
Vascular dysplasia: moyamoya, artery dissection
Hematologic disorders, coagulopathies, antiphospholipid
antibody syndrome
Cardiac muscle diseases, embolism
Vasculitis, connective tissue disorders
Metabolic diseases
MELAS, pyruvate dehydrogenase deﬁciency
Congenital disorders of glycosylation, homocystinuria
Neuromuscular diseases
Polio-like syndrome
Compression neuropathy
Epilepsy
Postictal paralysis, Rasmussen syndrome
Migraine
Familial hemiplegic migraine
Alternating hemiplegia of childhood
MELAS – mitochondrial encephalopathy, lactic acidosis, stroke-like
episodes.
Table 5 – Methods of evaluation in determining the
diagnosis of alternating hemiplegia of childhood (AHC).
Method Goal
Magnetic resonance, magnetic
resonance angiography,
spectroscopy of magnetic
resonance
To exclude structural central
nervous system abnormalities
(stroke, metabolic disorders)
or vasculopathies
Cerebrospinal ﬂuid examination:
glucose, lactic acid and
pyruvate, neurotransmitters,
metabolites of pterins, folates,
amino acids
To exclude disorders of
dopamine synthesis or
disorders associated
with pyridoxine or
folates deﬁciency
Metabolic screening tests of
blood and urine
To exclude mitochondrial
disorders, glucose-
transporter-deﬁciency,
organic acidurias or
carnitine deﬁciency
Thyroid gland examination To exclude periodic
paralysis associated with
hyperthyroidism
Video EEG (12-24-h monitoring) Registration of epileptic
seizures and non-epileptic
attacks
Genetic tests:
ATP1A3 To conﬁrm AHC
CACNA1A, ATP1A2, SLC1A3 Differential diagnosis (AHC
and FHM)
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 1 3 0 – 1 3 5 133History revealed two episodes of generalized tonic–clonic
seizures during childhood (when she was 4 and 10 years old),
and dysarthria during pregnancy. Her hemiplegic spells,
observed since she started to walk, lasted for minutes to
2 h, with decreasing frequency. The mother's uncle suffered
from alternating hemiplegia of limbs or unusual limbs
posturing, recurrent since his childhood but medical help
was not requested [18].
In 34 out of a group of 37 adults with AHC, the data on
employment status was available. Only one person was able to
work independently and the other 13 worked with assistants
[12].
6. Non-typical AHC cases
Sporadic AHC cases were reported with unusually mild course.
The onset was late and dystonic spells were more pronounced
than hemiplegic, and also the psychomotor development of
children was good. Contrary, in some patients the course of
AHC was severe, with atrophy of optic nerves atrophy or
hypoacusis [11,15,21]. Unusual AHC course caused the exclu-
sion of children from research group [4].
7. Differential diagnosis
Spectrum of clinical symptoms of AHC is broad, what makes
differentiated diagnosis difﬁcult. The progressive diseases
must be excluded, with the special attention to treatable
conditions. This is especially difﬁcult in young children, when
clinical manifestation is incomplete. Causes of acute hemi-
plegia in children are presented in Table 4 [4,11,16,17]. These
were speciﬁcally included among the most important causes
presented by Tenney et al. [14].
One of the disorders worth mentioning in the differential
diagnostics is benign nocturnal alternating hemiplegia of
childhood (BNAH), signiﬁcantly different from classic, severe
AHC. Typically, hemiplegic spells occurred during sleep, and
they were preceded by crying, rendering affection of parents.
Patients were conscious, sometimes agitated, they, however,
did not have involuntary movements or abnormal ocular
movements, and their psychomotor development was not
affected. The trait of transmission was also different,
associated with chromosome X. Benign nocturnal alternating
hemiplegia of childhood should be differentiated from
hemiplegic migraine, frontal lobe epilepsy, rolandic epilepsy,
Panayiotopoulos syndrome and sleep disorders [22,23].
8. Diagnostic tests
The identiﬁcation of ATP1A3 mutation in AHC patients was
the diagnostic turning point [5,6]. Despite the availability of
this new diagnostic tool allowing AHC conﬁrmation, it is still
necessary to use clinical criteria. Additional tests serve only to
exclude other diseases causing alternating hemiplegia
[15,21]. Individually, results of different tests were incorrect,
however, none were informative or characteristic enough to
serve as a tool to conﬁrm AHC. The examples of commonlyperformed tests according to Sweney et al. [4] were presented,
in Table 5. Results of neuroradiological tests were normal in
most cases, and only in single patients, especially severely
affected or older, changes were detected, including cerebellar
atrophy, polymicrogyria, syringomyelia or hippocampal
pathology [11,24]. Normal results were achieved in laboratory
tests, including ammonia, creatine kinase, mucopolysacchar-
ides, lysosomal enzymes and very long chain fatty acids
[21,25]. Some functional tests allowed registration of patho-
logical changes occurring during hemiplegic spells in
patients. Single-photon emission computed tomography
detected hypoperfusion of the hemisphere contralateral to
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were similar to dysfunction detected already in patients with
migraine but different from that seen in epilepsy. Positron
emission tomography revealed a decrease of glucose metab-
olism in the brain (frontal region) or cerebellum in some
patients during interictal period [4,12,15].
Magnetic resonance spectroscopy of skeletal muscle at
rest and after exercise revealed the presence of changes
resembling mitochondrial dysfunction. However, results of
muscle biopsy performed in individual patients did not
suggest signiﬁcant changes, with non-speciﬁc increase in
lipid content or mitochondrial enzyme activity changes
[25,26]. Skin biopsy, performed in few patients, revealed the
presence of cytoplasmatic vacuoles and also apoptosis in
vascular smooth muscle cells indicating similarities
between AHC and cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy (CADA-
SIL). Changes in MMP-9 (matrix metalloproteinase-9), TIMP-1
(tissue inhibitor MMP-1), were not speciﬁc for AHC – they
could reﬂect vasogenic changes, detected sometimes in
patients with migraine. The casual relation of migraine and
ischaemic stroke is still unclear. The levels of SP (substance P)
and CG-RP (calcitonin gene-related peptide) in AHC patients
were different than in patients with migraine, suggesting that
trigeminovascular theory does not apply to AHC. Changes in
SP may reﬂect dysfunction of autonomic nervous system in
AHC patients [27–29].
9. Genetics and pathomechanism of AHC
ATP1A3 mutations were likely to be responsible for at least 74%
of AHC cases, causing reductions in ATPase activity. None of
the mutations known to cause rapid-onset dystonia-parkin-
sonism was found in patients with AHC [6]. The ATP1A2
mutation was described earlier in patients with FHM associat-
ed with benign familial infantile seizures and also in a child
with overlapping AHC and FHM symptoms [30,31]. De novo
CACNA1A mutation was proved in monozygotic twins with
phenotype indicating a co-existence of FHM and atypical AHC
[32]. One family was also reported with AHC symptoms in
proband and other family members and also with the balanced
translocation 46, XY, t(3;9)(p26;q34); the same mutation,
however, was discovered in asymptomatic family member
[30]. Although in children with AHC the decrease of glucose
level was not detected in the cerebrospinal ﬂuid (CSF),
mutation of GLUT-1 was reported in one child presenting
AHC phenotype. In a classical syndrome of Glut1 deﬁciency,
signs and symptoms such epilepsy, retardation of psychomo-
tor development, spasticity, speech disorders, dystonia and
secondary microcephaly were usually observed [33,34].
10. AHC therapy
The majority of drugs given to patients diagnosed with AHC
since a syndrome was described, were ineffective. The best
therapeutic results were achieved with ﬂunarizine, which
became a drug of choice. In some patients, ﬂunarizine caused
the reduction of frequency, time and severity of hemiplegicspells but the effect was sometimes transient and satisfactory
only during ﬁrst stage of treatment. Nevertheless, after
therapy termination, exacerbation of disease was observed.
Although studies were not randomized and groups of patients
were small, the effectiveness of this drug in the prophylactic
treatment of patients with AHC is still reported. In AHC
patients, in whom ﬂunarizine was not effective since the
beginning (non-responders), other medication was applied,
including amantadine or acetazolamide [27]. The acute
management of attacks is difﬁcult; several drugs given to
abort hemiplegic spells were partially effective, including
chloral hydrate, diazepam or lorazepam. Neuroleptics,
propranolole, carnitine and coenzyme Q were ineffective in
AHC patients, and aripiprazole was reported as helpful only in
one case. Epilepsy was not drug-resistant in majority of patients
with AHC. Antiepileptic drugs were mostly ineffective to treat
symptoms other than seizures. Topiramate was the only drug
able to inﬂuence the severity of AHC in some patients [35].
11. Prognosis
The clinical course of AHC was more severe in sporadic cases
than in familial ones. Prognosis was signiﬁcantly inﬂuenced by
the age of onset, and especially early occurring hemiplegic spells
[13]. The development of children with neonatal-onset mani-
festation was severely affected. Recurrent convulsive status
epilepticus led to deterioration of psychomotor development
[16]. Although in some children motor dysfunctions caused
wheelchair-dependency, other patients were able to lead
independent life in adulthood. With maturation, hemiplegic
spells, as well as abnormal ocular movements were less
common also hypotonia was less severe. The natural AHC
course was ﬂuctuating and unpredictable, and in the long period
of time until adulthood, the progression was not always seen.
For this reason, the existence of AHC subtypes cannot be
excluded [12,17,21].
The newest achievement of research in the ﬁeld of AHC
genetics was the identiﬁcation of ATP1A3 mutation, presented
during 12th International Child Neurology Congress and
published in Nature Genetics and Lancet Neurology in 2012
[5,6]. The possibility of disease conﬁrmation opens new
perspectives, and new ﬁeld of research, including clinical
and epidemiological ones.
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